FDA Issues Final Rule to Regulate LDTs: Bill Morice, M.D., Ph.D.

Answers from the Lab

Content provided by Mayo Clinic Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mayo Clinic Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

2M ago 18:11

MP3•Episode home

In this special episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the final rule issued by the U.S. Food and Drug Administration (FDA) on April 29, 2024, to make explicit its plan to regulate laboratory-developed tests (LDT) as medical devices under the Federal Food, Drug, and Cosmetic Act.

Their discussion includes:

Highlighting key points, exceptions, and the phased implementation plan of the final rule.
How the FDA’s final rule compares to its proposed rule from last year.
How the news may impact laboratories, health systems, health agencies, and manufacturers.
Uncertainties that still remain regarding the future of laboratory-developed tests.

308 episodes

#Science #Fitness #Medicine #Mayo Clinic Podcast For Laboratory #Laboratory Medicine #Healthcare #Lab #Mayo Clinic #Clinical #Dlmp #Morice #Pritt